Metastasis resection after biomarker-guided chemotherapy extends survival to 61 months

▸ TREATMENT

In the IVOPAK II study, patients with initially nonresectable metastatic colorectal cancer who underwent secondary metastasis resection after biomarker-stratified first-line treatment had a median overall survival of 61 months versus 22 months for chemotherapy alone. (Oncology)